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ORIGINAL ARTICLE
Background/Aims: Based on preliminary in vitro data from a previous study, we proposed that 50 mg/kg
glutathione (GSH) would be adequate for suppressing reactive oxygen species in patients with acute paraquat
(PQ) intoxication.  
Methods: Serum levels of reactive oxygen metabolites (ROM) were measured before and after the administration
of 50 mg/kg GSH to each of five patients with acute PQ intoxication.  
Results: In one patient, extremely high pretreatment ROM levels began to decrease prior to GSH administration.
However, in the remaining four cases, ROM levels did not change significantly prior to GSH administration. ROM
levels decreased significantly after GSH administration in all cases. In two cases, ROM levels decreased below
that observed in the general population; one of these patients died after a cardiac arrest at 3 hours after PQ
ingestion, while the other represented the sole survivor of PQ intoxication observed in this study. In the survivor,
ROM levels decreased during the first 8 hours of GSH treatment, and finally dropped below the mean ROM level
observed in the general population. 
Conclusions: Treatment with 50 mg/kg GSH significantly suppressed serum ROM levels in PQ-intoxicated
patients. However, this dose was not sufficient to suppress ROM levels when the PQ concentration was extremely
high. (Korean J Intern Med 2010;25:282-287)
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INTRODUCTION
In recent decades, the benefits of natural antioxidant
vitamins, such as vitamins C and E, and the antioxidant
properties of green tea have been discussed in numerous
articles [1,2]. However, limited evidence exists regarding
the efficacy of antioxidants and the appropriate therapeutic
dose in a clinical setting. The optimal dose for a medication
is the median dose required to produce the desired effect
with no unfavorable side effect, and it is often determined
based on an analysis of the dose-response relationship
specific to the drug. Generally, the effect produced by a
drug varies with the concentration that is present at its site
of action, and usually approaches a maximum value,
beyond which a further increase in concentration produces
no additional effect. Thus, the effective dose of an
antioxidant is the dose at which the levels of harmful
reactive oxygen species (ROS) decrease, or the dose at
which ROS are significantly suppressed at the site of
action. ROS are formed primarily in cells; however, direct
measurement of ROS formation in cells is very difficult in
the clinical setting. Instead, several indirect methods have
been developed to measure free radicals and their
metabolites, such as malondialdehyde (MDA; the final
product of lipid peroxidation) [3] and hydroperoxides
(ROOH; intermediate products of lipid peroxidation) [4].Kim JH, et al. Glutathione & reactive oxygen metabolites    283
Paraquat (PQ; 1,1’-dimethyl-4,4’-bipyridium dichloride)
is one of the most widely used herbicides worldwide.
In humans, intentional or accidental ingestion of PQ is
frequently fatal, because of the very rapid formation of
very large amounts of ROS in the body [5]. Several
methods for suppressing the toxicity of PQ have been
attempted over the past 30 years. Unfortunately, most of
these methods have not proven effective, with the
outcome primarily determined by the degree of exposure
to PQ. Because PQ intoxication is characterized ROS-
mediated injury, intravenous antioxidant therapy may be
useful to attenuate short-term ROS generation and thus
mitigate acute PQ poisoning. We have reported previously
that the antioxidant glutathione (GSH) effectively
attenuates PQ-induced ROS generation in fibroblasts [6].
In a further study examining the kinetics of the GSH
metabolites cysteine (Cys) and methionine (Met), we
estimated that a dose of 50 mg/kg body weight GSH
would be sufficient to suppress PQ-induced ROS
generation by 50% [7]. The current study was carried out
to determine whether 50 mg/kg GSH suppresses the
generation of ROS in patients with acute PQ intoxication.
METHODS
Five patients with acute PQ intoxication were enrolled
in this study, which was approved by the Investigational
Review Board of Soonchunhyang Cheonan Hospital. All
procedures were performed after obtaining informed
consent from each patient.
The control case was a 39-year-old man who was
admitted to the ER 2 hours after the ingestion of 30 mg of
diazepam (Valium®). Special permission was given to
enroll this patient as a control. The patient received no
antioxidant treatment and was discharged from hospital
on day 3 without specific complaints.
All of the PQ intoxication patients arrived at the hospital
within 3 hours after the intentional ingestion of the
poison. They were admitted to the Institute of Pesticide
Poisoning, Soonchunhyang University Cheonan Hospital,
between January and September 2009.
Baseline laboratory findings for cases 1 to 5 are
summarized in Table 1. In addition, a mean value for
serum reactive oxygen metabolites (ROM) in the general
population was obtained from 60 healthy adults between
30 and 60 years of age. 
Standard medical emergency procedures were followed.
Briefly, gastric lavage was performed on all subjects who
presented to the emergency room (ER) within 2 hours of
PQ ingestion. Patients who presented to the ER more than
2 hours after PQ ingestion were given 100 g of Fuller’s
earth in 200 mL of 20% mannitol. Hemoperfusion was
performed on patients showing positive urinary PQ tests
upon arrival at the ER. Intravenous administration of
GSH (50 mg/kg body weight) was started 1 hour after the
Table 1. Baseline laboratory findings of the subjects
Case 1 Case 2 Case 3 Case 4 Case 5 Control
Age, yr 64 28 68 76 70 39
Plasma PQ level, µg/mL 92.07 77.7 1.88 176.3 22.9 0
MDA 10.6 15.8 20.0 15.0 17.5 10.0
WBC, cells/mm3 27,900 17,800 8,210 17,900 36,400 6,910
Albumin, g/dL 4.5 5.2 4.7 4.8 4.9 4.7
Total bilirubin, mg/dL 0.3 1.8 1.3 1.6 0.3 0.7
AST, IU/L 54 20 18 38 26 18
ALT, IU/L 24 19 6 24 14 9
Amylase, IU/L 120 120 98 214 184 92
Lipase, IU/L 53 45 36 78 39 20
Blood urea nitrogen, mg/dL 12.5 11.2 21.1 22.6 23.9 5.8
Creatinine, mg/dL 1.6 1.4 0.6 4.2 1.0 0.9
Uric acid, mg/dL 7.9 6.5 7.6 6.3 8.2 6.8
pH 7.26 7.36 7.45 7.30 7.23 7.35
PaO2, mmHg 119.7 75.6 72.2 76.6 71.9 88.0
Clinical outcome Dead Dead Alive Dead Dead Alive
PQ, paraquat; MDA, malondialdehyde; WBC, white blood cell; AST, aspartate aminotransferase; ALT, alanine aminotransferase.284 The Korean Journal of Internal Medicine Vol. 25, No. 3, September 2010
first blood sample was taken and continued over the next
12 hours.
The amount of PQ ingested was estimated based on
the number of swallows reported by the patient (one
mouthful was considered to be 20 mL). High-resolution
computed tomography (HRCT) was performed 7 days
after ingestion to detect damage to the lung, and an
additional follow-up HRCT was performed 1 week later if
any abnormality was detected. Survivors were defined as
those patients who survived for more than 3 months after
PQ ingestion, maintained stable vital signs, and did not
report specific complaints.
Urinary PQ levels were measured semiquantitatively
using the dithionite method, whereas plasma PQ levels
were evaluated by high-performance liquid chromatography.
MDA levels were measured using an assay kit (NWLSSTM,
Northwest Life Science Specialties, Vancouver, Canada);
this test is based on the reaction between MDA and
thiobarbituric acid (TBA), which forms an MDA-(TBA)2
adduct that strongly absorbs at 532 nm.
ROMs (free radical-derived compounds) in serum were
measured using a commercially available assay kit (d-
ROM Test, Diacron International, Grosseto, Italy). The
test is based on the capacity of iron to break down ROOH,
forming alkoxyl (RO.) and peroxyl (ROO.) radicals; the
quantity of these compounds is directly proportional
to the quantity of the ROOH present in the sample.
Thereafter, RO. and ROO. are chemically trapped by the
chromogen substrate. The results of the d-ROM test are
expressed in Carratelli units (CARR) according to the
following formula: 1 CARR = (Abs/min) × F (a correction
factor with an assigned value, according to the results
obtained with the calibrator) = 0.08 mg H2O2/dL.
The initial blood sampling was performed upon the
patient’s arrival at the ER to determine baseline levels of
MDA, complete blood count, blood chemistry, and ROM
level. Additional blood samples were collected hourly until
8 hours after PQ ingestion. In cases 2, 3, and 4, an
additional sample was obtained at 30 minutes after the
first sample. Case 4 died very early on the first day, for
which reason only four samples were collected from this
patient. For the control (diazepam) case, blood samples
were collected every 30 minutes for the first 2 hours, and
then on the hour for an additional two more hours (Fig. 1).
RESULTS
The mean ROM level (± SD) among the general
population was 289.6 ± 58.8 CARR (range, 202 to 350).
In the control case (diazepam ingestion), seven sequential
measurements were used to calculate a mean ROM level
of 272.7 ± 12.7 CARR (range, 255.0 to 289.0).
Case 1 was a 64-year-old man in whom hemoperfusion
was initiated 1 hour after admission. He died 17 hours
after PQ ingestion. His plasma PQ level was 92.1 µg/mL at
3 hours after PQ ingestion with an initial ROM level of
940 CARR. This level decreased to 733 CARR 1 hour later
without GSH administration. The patient’s ROM levels at
1, 2, 3, and 4 hours after the initiation of GSH administration
were 624, 640, 586, and 517 CARR, respectively.
Case 2 was a 28-year-old man who was admitted to the
ER 3 hours after ingesting four mouthfuls of PQ. Despite
intensive therapy, he died 24 hours after PQ ingestion. His
plasma PQ level was 77.7 µg/mL at 3 hours after PQ
ingestion with an initial ROM level of 513 CARR. This
level was stable for 1 hour (526 CARR at 30 minutes, 523
CARR at 60 minutes) until GSH administration. After
GSH administration, ROM levels decreased, to 338 and
323 CARR at 1 and 2 hours post-administration,
respectively, but then rebounded to 402 and 395 CARR at
3 and 4 hours post-administration, respectively.
Case 3 was a 68-year-old man who arrived at the ER 2
Figure 1. Sequential changes in reactive oxygen metabolite
(ROM) levels. The arrow indicates the initiation of intravenous
glutathione (GSH) administration at 50 mg/kg body weight.
The control case is a patient with diazepam intoxication. In case
3, the patient’s serum ROM level decreased gradually to a value
below that of the mean of the general population; this patient
was the sole survivor of the five cases of paraquat intoxication.
The three horizontal dotted lines indicate the mean serum
ROM (± SD) of the age- and gender-matched general healthy
population (290 ± 59 Carratelli units).Kim JH, et al. Glutathione & reactive oxygen metabolites    285
hours after ingesting one mouthful of PQ. The patient’s
plasma PQ level was 1.18 µg/mL at 2 hours after PQ
ingestion with pre-GSH ROM levels of 450 CARR at
baseline, 441 CARR 30 minutes later, and 427 CARR at 1
hour, and 426 CARR at 2 hours after PQ ingestion. The
patient’s ROM levels decreased to 332, 319, and 281
CARR at 3, 4, and 5 hours, respectively, after GSH
administration. HRCT of the lungs was performed on day
7 after admission and showed no evidence of PQ-induced
lung injury. The patient was discharged on day 8 without
complaints. This case was the sole survivor of the PQ
intoxication patients observed here.
Case 4 was a 76-year-old man who arrived at the ER 1
hour after ingesting 200 mL of PQ. He developed unstable
vital signs (blood pressure 80/50 mmHg) and hypoxia 1
hour after starting hemoperfusion, and died 2 hours after
PQ ingestion. The patient’s plasma PQ level was 176.3
µg/mL at 1 hour after PQ ingestion, and his ROM levels
were 555 CARR at baseline, 545 CARR 30 minutes later,
and 534 CARR 1 hour later. The patient’s ROM levels
decreased further to 269 CARR at 1 hour after GSH
administration.
Case 5 was a 70-year-old man who arrived at the ER 2
hours after ingesting four mouthfuls of PQ. He died 41
hours after PQ ingestion. His PQ level was 22.9 µg/mL at
2 hours after PQ ingestion. ROM levels before GSH
administration were 555 CARR at baseline and 486 CARR
at 1 hour later. At 1, 2, 3, 4, and 5 hours after the initiation
of intravenous GSH administration, the patient showed
fluctuating plasma ROM levels of 399, 369, 397, 433, and
388 CARR, respectively.
In summary, 50 mg/kg GSH significantly suppressed
ROM levels (mean pre-GSH ROM level, 540.4 ± 115.6;
mean post-GSH ROM level, 392.4 ± 137.4; p = 0.04,
Wilcoxon signed rank test), but this treatment elicited no
effect when the PQ concentration was extremely high.
ROM levels in the sole survivor of this study decreased
monotonically during the first 8 hours of observation, and
finally settled below the mean ROM level observed in the
general population. However, in all of the patients who
died, the lowest observed ROM level still exceeded that of
the general population
DISCUSSION
Sulfur-containing compounds have been examined as
antioxidants in PQ-induced lung injury, because of their
inherent antioxidant properties and the early observation
that the depletion of reduced GSH enhanced PQ toxicity
[8]. Although some studies have shown that alveolar type
II cells can supplement the endogenous synthesis of GSH
by the uptake of exogenous GSH [9,10], the antioxidative
effect of exogenously administered GSH is attenuated by
its instability when crossing cell membranes and its rapid
hydrolysis while in circulation [11-13].
In the circulatory system, GSH is degraded rapidly by
gamma-glutamyltranspeptidase, an enzyme found on
the extracellular surfaces of cells, yielding glutamate, Cys,
and glycine [14]. In some cells, the degradation of GSH at
the cell surface directly provides the cells with the Cys
required for GSH synthesis [15]. Although Cys is a critical
amino acid for the synthesis of GSH, it is quite reactive in
the circulation, resulting in large amounts of Cys being
immediately oxidized to Cys2.
In our preliminary study [6,7], the effective doses of
Cys, Cys2, and Met against PQ-induced ROS generation in
fibroblast cells were assessed using laser scanning confocal
microscopy. Both Cys and Met suppressed ROS in a dose-
dependent manner at concentrations of 1 to 1,000 µM [6];
the concentrations required to suppress ROS by 50%
were 20 µM for Cys and 50 µM for Met. Using metabolite
kinetics, with the assumption that Cys and Met are the
metabolites of GSH, we estimated that a GSH dose of 50
mg/kg body weight (administered at 205-minutes intervals)
is sufficient to produce a serum Cys concentration of 20
µM; likewise, this dose of GSH is sufficient to produce a
serum Met concentration of 50 µM when administered at
intervals of 427 minutes [7]. Accordingly, a treatment
dose of 50 mg/kg GSH was used in this pilot study to
examine the effectiveness of intravenous antioxidant
therapy against acute PQ toxicity.
To our knowledge, this is the first report of the sequential
changes in ROM levels in patients with acute PQ intoxi-
cation, during which large quantities of ROS are thought
to be generated. ROM levels decreased rapidly after the
intravenous administration of GHS (50 mg/kg) in all
subjects. However, in three (cases 1, 2, and 5) of the four
patients who did not survive (cases 1, 2, 4, and 5), the final
observed ROM levels remained higher than the mean
value in the general population. This suggests that a dose
of 50 mg/kg GSH is insufficient to counter the high
levels of ROS generated as a result of PQ intoxication.
Furthermore, case 4 died of cardiac arrest 3 hours after
PQ ingestion, even after ROM levels had decreased to
within the normal range, suggesting that plasma ROM286 The Korean Journal of Internal Medicine Vol. 25, No. 3, September 2010
level is not an absolute clinical marker for survival after
PQ intoxication.
A limitation of this study is that the sample group was
too small for valid statistical analyses. Although acute PQ
intoxication provides an invaluable opportunity to observe
the clinical characteristics of acute ROS-mediated disease,
we encountered difficulties enrolling patients in the study.
Most patients with acute PQ intoxication are in a critical
state when they arrive at the ER, and typically demonstrate
rapid progression/deterioration and a subsequently high
mortality rate. In the interest of providing the patient with
prompt, high-quality emergency care, there is rarely time
to discuss the study objectives with the patient’s family
and obtain permission to enroll him or her in a clinical
study. As such, we were only able to enroll five patients for
the present study.
There is also doubt as to the adequacy of the 50 mg/kg
dose of GSH used here. This dose was calculated from
data obtained using fibroblast cells [6], corresponding to
the concentration required to suppress PQ-induced ROS
generation by 50%. This raises the question as to whether
in vitro results can be applied directly to in vivo situations
without any modification. The intensity of ROS formation
and the suppression of ROS by the antioxidant may differ
under the two conditions, but there is no available way of
addressing both aspects.
It is also unclear whether plasma ROM levels area
actually reliable markers of ROS formation in cells. We
recently reported that neither cross-sectional nor sequential
measurements of plasma MDA provided reliable data on
ROS formation in patients with acute PQ intoxication
(based on repeated measurements of MDA) [16]. The
present study confirmed that ROM measurements were
reproducible: they remained stable in a patient with
diazepam intoxication (7 measurements made over a 4-
hour period; Fig. 1). This suggests that the intermediate
products of lipid peroxidation may be more reliable than
the end-products; that is, ROMs may be a more reliable
marker of ROS formation than markers such as MDA that
are currently used.
In conclusion, ROM levels were higher in patients with
acute PQ intoxication. However, there was no apparent
association between plasma PQ and plasma ROM. Plasma
ROM levels decreased immediately after initiating the
intravenous administration of 50 mg/kg GSH in all
patients with PQ intoxication, but not sufficiently so when
the PQ concentration was particularly high (i.e., case 5,
22.9 µg/mL at 2 hours after PQ ingestion; case 1, 92.1
µg/mL after PQ ingestion; case 2, 77.7 µg/mL at 3 hours
after PQ ingestion). Levels of ROMs in the sole survivor
(case 3) decreased monotonically during the first 8 hours
of close observation, and thereafter remained at levels
similar to those in the general population. 
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